Psykey, Inc. (OTCMKTS:CEOS) Sees Significant Decline in Short Interest

Psykey, Inc. (OTCMKTS:CEOS) was the recipient of a large decrease in short interest in November. As of November 15th, there was short interest totalling 2,400 shares, a decrease of 79.8% from the October 31st total of 11,900 shares. Based on an average daily volume of 877,900 shares, the short-interest ratio is currently 0.0 days.

Psykey Stock Performance

CEOS traded up $0.00 during midday trading on Friday, reaching $0.03. The company had a trading volume of 1,163,104 shares, compared to its average volume of 577,683. Psykey has a 1 year low of $0.01 and a 1 year high of $0.05. The business has a 50-day moving average of $0.02 and a two-hundred day moving average of $0.02.

About Psykey

Psykey, Inc engages in the research, development, and commercialization of entheogenic, adaptogenic, and nootropic ingredients and formulations for its functional product lines to improve and optimize life. The company also engages in the development of technologies for the composition, bioavailability, and targeted delivery of entheogen-based therapeutics for the psychedelic market.